Informations techniques
Exploitant
VIFOR FRANCE S.A.
Présentation
VELTASSA 8,4 g, poudre pour suspension orale (non disponible)
B/30 (CIP : 34009 301 240 4 8)
VELTASSA 16,8 g, poudre pour suspension orale (non disponible)
B/30 (CIP : 34009 301 240 5 5)
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
HAwN4RRES3SEtVah